Home › FDA Approves Merck's NOXAFIL (posaconazole) Injection (18 mg/mL) for Intravenous Use
 

Keywords :   


FDA Approves Merck's NOXAFIL (posaconazole) Injection (18 mg/mL) for Intravenous Use

2014-03-15 04:54:54| Biotech - Topix.net

Merck , known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved NOXAFIL injection , a new formulation of NOXAFIL for intravenous use.

Tags: use injection fda approves

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Boeing strike ends as workers back 38% pay rise deal
05.11Tropical Storm Rafael Public Advisory Number 6A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Graphics
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 6
More »